CMV Clinical Trials in Seoul
5 recruitingSeoul, South Korea
Showing 1–5 of 5 trials
Recruiting
Not Applicable
Evaluation of Safety and Efficacy of Virus Specific T-Cell Administration in Pediatric Patients With Systemic Viral Infection Following Allogeneic Hematopoietic Stem Cell Transplantation.
EBV InfectionCMV InfectionBKV Infection
LucasBio6 enrolled1 locationNCT07685457
Recruiting
Not Applicable
Evaluation of Safety and Efficacy of Autologous LB-DTK-CMV in Patients With Antiviral-Resistant and Refractory Cytomegalovirus Retinitis.
CMV Retinitis
LucasBio5 enrolled1 locationNCT07679412
Recruiting
Phase 1Phase 2
Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation.
EBV InfectionCMV InfectionBKV Infection
LucasBio27 enrolled1 locationNCT07670468
Recruiting
Phase 2
Phase II Trial of Maribavir for CMV in Patients With Lymphoid Malignancy on Bispecific Antibodies
Cytomegalovirus (CMV)
Seoul National University Hospital20 enrolled1 locationNCT07014319
Recruiting
A Study of LIVTENCITY (Maribavir) in Adults With Cytomegalovirus (CMV) Infection After Transplantation in South Korea
Cytomegalovirus (CMV)
Takeda168 enrolled1 locationNCT06555432